Vaccine plant in Singapore for pneumonia by GSK
On Tuesday, drug maker GlaxoSmithKline (GSK), established a US $600 million plant in Singapore that is stated to begin producing anti-pneumonia vaccine in 2011.
VACCINE-PLANT-IN-SINGAPORE-FOR-PNEUMONIA-BY-GSK
